Fri Oct 04 05:37:07 UTC 2024: ## Cognex Receives “Moderate Buy” Rating from Analysts, Target Price $49.62
**MarketBeat News** – Cognex Corporation (NASDAQ: CGNX), a leading provider of machine vision products, has been assigned a consensus rating of “Moderate Buy” by thirteen research firms currently covering the company. This rating is based on one “Sell” recommendation, four “Hold” recommendations, seven “Buy” recommendations, and one “Strong Buy” recommendation.
Analysts anticipate a twelve-month price objective of $49.62 for CGNX stock.
Recent research reports on Cognex have produced a mixed outlook. While Vertical Research initiated coverage with a “Buy” rating and a $58.00 target price, Truist Financial downgraded their price objective to $46.00 but maintained a “Buy” rating. DA Davidson and Robert W. Baird both lowered their price objectives and assigned “Neutral” ratings. StockNews.com upgraded the company from “Sell” to “Hold.”
Institutional investors have been active in Cognex stock. Massmutual Trust Co. FSB ADV, Rise Advisors LLC, BI Asset Management Fondsmaeglerselskab A S, and GAMMA Investing LLC all increased their positions in the first and second quarters. Point72 Hong Kong Ltd acquired a new position in Cognex during the second quarter. Currently, 88.12% of CGNX stock is owned by institutional investors and hedge funds.
Cognex’s recent earnings report showed strong performance, exceeding analyst expectations for both earnings per share and revenue. However, revenue decreased by 1.6% year-over-year.
Cognex also declared a quarterly dividend, paying $0.075 per share to shareholders.
Overall, analysts remain optimistic about Cognex’s future prospects, with the “Moderate Buy” rating suggesting a positive outlook for the company’s stock. The company’s recent earnings performance, combined with active participation from institutional investors, further supports this optimistic view.
First Piper 